---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-003571"
form_type: "8-K"
ticker: "FBLG"
cik: "0001958777"
company_name: "FibroBiologics, Inc."
filed_at: "2025-01-24T23:59:59+00:00"
generated_at: "2026-05-27T11:56:53.421838+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# FibroBiologics board approves 2024 incentive bonuses for CEO O'Heeron and other executives

## Summary
- CEO Pete O'Heeron received $390,000 non-equity incentive bonus, total compensation $1,805,199 for 2024.
- CSO Hamid Khoja received $150,000 bonus, total compensation $853,646.
- GC Ruben Garcia (hired March 2024) received $142,188 bonus, total compensation $2,752,843 including option grant.
- Interim CFO Robert Hoffman awarded a $75,000 bonus for 2024.
- Bonuses were previously undetermined and approved on January 23, 2025.

## SEC filing metadata
- accession: 0001493152-25-003571
- form_type: 8-K
- ticker: FBLG
- cik: 0001958777
- company_name: FibroBiologics, Inc.
- filed_at: 2025-01-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958777/000149315225003571/0001493152-25-003571-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958777/000149315225003571/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-003571
- JSON: https://secwatch.observer/filing/0001493152-25-003571.json
- Plain text: https://secwatch.observer/filing/0001493152-25-003571.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.